Moderna gains approval for updated COVID-19 vaccines (MRNA:NASDAQ)
· seekingalpha.com
FDA approves Moderna’s Spikevax and mNEXSPIKE for 2026-27, targeting JN.1 XFG subvariant. Read more here.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...